Karen L. Smith - May 16, 2022 Form 3 Insider Report for Talaris Therapeutics, Inc. (TALS)

Role
Director
Signature
/s/ Mary Kay Fenton, as Attorney-in-Fact
Stock symbol
TALS
Transactions as of
May 16, 2022
Transactions value $
$0
Form type
3
Date filed
5/17/2022, 06:12 PM
Previous filing
Mar 1, 2022
Next filing
May 23, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney